BDKRB1 抗体 (Internal Region)
-
- 抗原 See all BDKRB1 抗体
- BDKRB1 (Bradykinin Receptor B1 (BDKRB1))
-
抗原表位
- Internal Region
-
适用
- 人
-
宿主
- 山羊
-
克隆类型
- 多克隆
-
标记
- This BDKRB1 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), Enzyme Immunoassay (EIA)
- 特异性
- This antibody reacts to Bradykinin receptor B1.
- 纯化方法
- Affinity chromatography
- 免疫原
- Peptide with sequence KVWELYKQCTPK, from the internal region of the protein sequence
- Top Product
- Discover our top product BDKRB1 Primary Antibody
-
-
- 应用备注
-
Peptide ELISA: 1/1000. Western Blot: 2 - 4 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. - 限制
- 仅限研究用
-
- 浓度
- 0,5 mg/mL
- 缓冲液
- Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin
- 储存液
- Sodium azide
- 注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 注意事项
- Avoid repeated freezing and thawing.
- 储存条件
- 4 °C/-20 °C
- 储存方法
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
Genetic variation and gender determine bradykinin type 1 receptor responses in human tissue: implications for the ACE-inhibitor-induced effects in patients with coronary artery disease." in: Clinical science (London, England : 1979), Vol. 126, Issue 6, pp. 441-9, (2014) (PubMed).
: "
-
Genetic variation and gender determine bradykinin type 1 receptor responses in human tissue: implications for the ACE-inhibitor-induced effects in patients with coronary artery disease." in: Clinical science (London, England : 1979), Vol. 126, Issue 6, pp. 441-9, (2014) (PubMed).
-
- 抗原
- BDKRB1 (Bradykinin Receptor B1 (BDKRB1))
- 别名
- BDKRB1 (BDKRB1 产品)
- 别名
- bdkrb2 antibody, LOC100230525 antibody, B1BKR antibody, B1R antibody, BKB1R antibody, BKR1 antibody, BRADYB1 antibody, BKR antibody, Bdkrb antibody, b1bkr antibody, bradykinin receptor B1 antibody, bradykinin receptor, beta 1 antibody, bdkrb1 antibody, BDKRB1 antibody, Bdkrb1 antibody
- 背景
- Bradykinin, a 9 aa peptide, is generated in pathophysiologic conditions such as inflammation, trauma, burns, shock, and allergy. Two types of G-protein coupled receptors have been found which bind bradykinin and mediate responses to these pathophysiologic conditions. The protein encoded by this gene is one of these receptors and is synthesized de novo following tissue injury. Receptor binding leads to an increase in the cytosolic calcium ion concentration, ultimately resulting in chronic and acute inflammatory responses. Bradykinin B1 receptor is generally only minimally expressed under normal physiological conditions, but the expression is induced rapidly under pathologic conditions such as ischemia, atheromatous disease, or exposure to inflammatory cytokines.Synonyms: B1 bradykinin receptor, B1R, BK-1 receptor, BKB1R, BKR1, BRADYB1, Bradykinin B1 Receptor
- 基因ID
- 623
- NCBI登录号
- NP_000701
- UniProt
- P46663
- 途径
- ACE Inhibitor Pathway
-